Sanofi (SNY)

48.02
0.08 0.17
NASDAQ : Health Technology
Prev Close 47.94
Open 48.30
Day Low/High 48.04 / 48.30
52 Wk Low/High 44.76 / 54.26
Volume 442.78K
Avg Volume 1.74M
Exchange NASDAQ
Shares Outstanding 2.51B
Market Cap 129.93B
EPS 1.30
P/E Ratio 26.71
Div & Yield 1.17 (2.28%)

Latest News

B&G Foods Piques My Interest but Has Yet to Whet My Appetite Enough to Buy

B&G Foods Piques My Interest but Has Yet to Whet My Appetite Enough to Buy

The company behind a diverse roster of shelf and frozen foods sports a big dividend, but that payout may not last because of its large debt.

Biden Bits, Vaccine Vanguard, Unmasking Folly, Minerd Musings, Ives Inklings

Biden Bits, Vaccine Vanguard, Unmasking Folly, Minerd Musings, Ives Inklings

Among other things, the president works to align Democratic senators to support his massive Covid relief bill.

Wait for Strength Before Buying Sanofi

Wait for Strength Before Buying Sanofi

Let's review the charts and indicators.

Short Story Ends, Watching Curves, Enter J&J, Flexible FDA, Ford Impresses

Short Story Ends, Watching Curves, Enter J&J, Flexible FDA, Ford Impresses

Plus, Thursday was a solid day for nearly all sectors of the market, though Peloton Interactive pulls back after posting results.

Tough Jobs Stuff, Winter Economic Chill, Vaccine Hiccup, Disney Delights

Tough Jobs Stuff, Winter Economic Chill, Vaccine Hiccup, Disney Delights

Plus, stay nimble as the road just ahead could become a bit more treacherous than many may think.

Mysterious Mnuchin, Vaccines at the Ready, Carnival Isn't Cruising, 2 Big 'W's

Mysterious Mnuchin, Vaccines at the Ready, Carnival Isn't Cruising, 2 Big 'W's

A look at the charts of Advanced Micro Devices and Tesla, plus a review of the 'broadening' market action from Thursday.

Sanofi Could Trade Sideways for the Weeks Ahead

Sanofi Could Trade Sideways for the Weeks Ahead

I would consider SNY a hold at this point in time.

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.

Jim Cramer: Let's Look Behind the Scenes Amid the Fall

Jim Cramer: Let's Look Behind the Scenes Amid the Fall

Often hidden reasons are lurking below when there's maximum confusion, and here's what they are.

Weakening Dollar, Fiscal Relief Gridlock, Walmart+, Trading Albemarle

Weakening Dollar, Fiscal Relief Gridlock, Walmart+, Trading Albemarle

Also, interpreting Tuesday's market, Covid-19 vaccine update, and manufacturing growth.

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.

Novavax and Its $1.6 Billion Award Just Got My Attention

Novavax and Its $1.6 Billion Award Just Got My Attention

The smallish clinical-stage vaccine company looks like a trade, not an investment, and might be approached as an option play.

Pandora's Scary Box, Apple Optimism?, Regeneron, Trading Sanofi

Pandora's Scary Box, Apple Optimism?, Regeneron, Trading Sanofi

Markets are clearly different now. I did not grow up, nor was I trained for this environment. Nobody else you hear today was either.

Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago

Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago

So what's the narrative? Simple: the recession is ending, it turned out to be a V recession and recovery after all.

Floor Traders Return to NYSE, Novavax Vaccine News, Be Amphibious

Floor Traders Return to NYSE, Novavax Vaccine News, Be Amphibious

The return of NYSE floor traders is symbolic of the return to normalcy, as vaccine candidate manufacturers are scaling up for mass production.

Moderna Is a Breath of Fresh Air

Moderna Is a Breath of Fresh Air

I'm long this name, as I am several of the others involved. Will I add on a day like this?

Powell's Reassurance, Nvidia's Breakout Higher, Trading Thoughts

Powell's Reassurance, Nvidia's Breakout Higher, Trading Thoughts

Jerome Powell hit the airwaves with some words of caution and comfort. Nvidia is running into earnings.

Sell Signals, 'Operation Warp Speed,' Trading Notes

Sell Signals, 'Operation Warp Speed,' Trading Notes

Trump administration taps former GlaxoSmithKline exec as head of vaccine task force, and how I'm playing Walmart and Datadog.

Here's a Quartet of Small Biotechs That Could Make for Acquisition Targets

Here's a Quartet of Small Biotechs That Could Make for Acquisition Targets

Merger activity is picking up this week in the biotechnology sector and these four promising companies would be good buyout candidates.

Jim Cramer: Reopening Is Necessary, but Based on Little More Than Hope

Jim Cramer: Reopening Is Necessary, but Based on Little More Than Hope

It's imperative that people get back to work, so we have this great compromise -- let's see how it might play out.

Saving the Service Economy, Gilead Trials and Intel's Earnings: Market Recon

Saving the Service Economy, Gilead Trials and Intel's Earnings: Market Recon

More government funding is approved to fight Covid-19 layoffs, Gilead sells off on early reports around China trials and Intel announces earnings.

GlaxoSmithKline Charts Prescribe Positive Outlook as It Chases Covid-19 Vaccine

GlaxoSmithKline Charts Prescribe Positive Outlook as It Chases Covid-19 Vaccine

The drugmaker that is partnering with Sanofi to develop a vaccine has seen its shares push higher after declining to a low in late March.

Jim Cramer: Don't Mistake the Rally for Cheering

Jim Cramer: Don't Mistake the Rally for Cheering

There is no joy in stockville -- instead we have big companies with stocks rising. Here's why that is and what you need to understand about the rally amid the crisis.

Sanofi's Charts Show Upside Potential Amid Its Covid-19 Work

Sanofi's Charts Show Upside Potential Amid Its Covid-19 Work

The drug and vaccine maker possibly could see its shares double according to a key chart.

Mild Good News as Japanese Flu Drug Shows Promise in Mild Covid-19 Cases

Mild Good News as Japanese Flu Drug Shows Promise in Mild Covid-19 Cases

Fujifilm Holdings has a promising drug that seems to work in improving the outcome for coronavirus patients in China and Japan, though Avigan is a treatment not a cure.

The Magic Mice of Regeneron

The Magic Mice of Regeneron

I am pretty well covered in my 'virus group'. I could definitely see bringing a few shares of REGN on board the next time the algorithms include that name in a broad selloff. Not before.

5 Leading Biotechs in Search of a Coronavirus Vaccine

5 Leading Biotechs in Search of a Coronavirus Vaccine

The race is on. The prize could be countless lives saved and perhaps billions of dollars in revenue.

4 Favorite Biotech Stock Picks for 2020

4 Favorite Biotech Stock Picks for 2020

The Medical Technology Stock Letter's top pick rose 357% in 2019.